49 related articles for article (PubMed ID: 18409068)
1. Src inhibitors in early breast cancer: a methodology, feasibility and variability study.
Jones RJ; Young O; Renshaw L; Jacobs V; Fennell M; Marshall A; Green TP; Elvin P; Womack C; Clack G; Dixon JM
Breast Cancer Res Treat; 2009 Mar; 114(2):211-21. PubMed ID: 18409068
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effects and biomarkers of activity of AZD0530, a Src inhibitor, in pancreatic cancer.
Rajeshkumar NV; Tan AC; De Oliveira E; Womack C; Wombwell H; Morgan S; Warren MV; Walker J; Green TP; Jimeno A; Messersmith WA; Hidalgo M
Clin Cancer Res; 2009 Jun; 15(12):4138-46. PubMed ID: 19509160
[TBL] [Abstract][Full Text] [Related]
3. Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530.
Green TP; Fennell M; Whittaker R; Curwen J; Jacobs V; Allen J; Logie A; Hargreaves J; Hickinson DM; Wilkinson RW; Elvin P; Boyer B; Carragher N; Plé PA; Bermingham A; Holdgate GA; Ward WH; Hennequin LF; Davies BR; Costello GF
Mol Oncol; 2009 Jun; 3(3):248-61. PubMed ID: 19393585
[TBL] [Abstract][Full Text] [Related]
4. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
5. Impact of the Src inhibitor saracatinib on the metastatic phenotype of a fibrosarcoma (KHT) tumor model.
Dong M; Rice L; Lepler S; Pampo C; Siemann DW
Anticancer Res; 2010 Nov; 30(11):4405-13. PubMed ID: 21115886
[TBL] [Abstract][Full Text] [Related]
6. Denbinobin suppresses breast cancer metastasis through the inhibition of Src-mediated signaling pathways.
Chen PH; Peng CY; Pai HC; Teng CM; Chen CC; Yang CR
J Nutr Biochem; 2011 Aug; 22(8):732-40. PubMed ID: 21062671
[TBL] [Abstract][Full Text] [Related]
7. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma.
Madan R; Smolkin MB; Cocker R; Fayyad R; Oktay MH
Hum Pathol; 2006 Jan; 37(1):9-15. PubMed ID: 16360410
[TBL] [Abstract][Full Text] [Related]
8. Involvement of focal adhesion kinase in inhibition of motility of human breast cancer cells by sphingosine 1-phosphate.
Wang F; Nohara K; Olivera A; Thompson EW; Spiegel S
Exp Cell Res; 1999 Feb; 247(1):17-28. PubMed ID: 10047444
[TBL] [Abstract][Full Text] [Related]
9. Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of SRC-transformed cells.
Brábek J; Constancio SS; Siesser PF; Shin NY; Pozzi A; Hanks SK
Mol Cancer Res; 2005 Jun; 3(6):307-15. PubMed ID: 15972849
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II induces focal adhesion kinase/paxillin phosphorylation and cell migration in human umbilical vein endothelial cells.
Montiel M; de la Blanca EP; Jiménez E
Biochem Biophys Res Commun; 2005 Feb; 327(4):971-8. PubMed ID: 15652490
[TBL] [Abstract][Full Text] [Related]
11. Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells.
Hiscox S; Jordan NJ; Smith C; James M; Morgan L; Taylor KM; Green TP; Nicholson RI
Breast Cancer Res Treat; 2009 May; 115(1):57-67. PubMed ID: 18493848
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells.
Zhu WY; Jones CS; Amin S; Matsukuma K; Haque M; Vuligonda V; Chandraratna RA; De Luca LM
Cancer Res; 1999 Jan; 59(1):85-90. PubMed ID: 9892191
[TBL] [Abstract][Full Text] [Related]
13. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.
Chen LC; Tu SH; Huang CS; Chen CS; Ho CT; Lin HW; Lee CH; Chang HW; Chang CH; Wu CH; Lee WS; Ho YS
Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Src with AZD0530 reveals the Src-Focal Adhesion kinase complex as a novel therapeutic target in papillary and anaplastic thyroid cancer.
Schweppe RE; Kerege AA; French JD; Sharma V; Grzywa RL; Haugen BR
J Clin Endocrinol Metab; 2009 Jun; 94(6):2199-203. PubMed ID: 19293266
[TBL] [Abstract][Full Text] [Related]
15. MLK3 regulates paxillin phosphorylation in chemokine-mediated breast cancer cell migration and invasion to drive metastasis.
Chen J; Gallo KA
Cancer Res; 2012 Aug; 72(16):4130-40. PubMed ID: 22700880
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a new class of anilinoquinazoline inhibitors with high affinity and specificity for the tyrosine kinase domain of c-Src.
Plé PA; Green TP; Hennequin LF; Curwen J; Fennell M; Allen J; Lambert-Van Der Brempt C; Costello G
J Med Chem; 2004 Feb; 47(4):871-87. PubMed ID: 14761189
[TBL] [Abstract][Full Text] [Related]
17. The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillin.
Guvakova MA; Surmacz E
Exp Cell Res; 1999 Aug; 251(1):244-55. PubMed ID: 10438590
[TBL] [Abstract][Full Text] [Related]
18. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
[TBL] [Abstract][Full Text] [Related]
19. The impact of delay in cryo-fixation on biomarkers of Src tyrosine kinase activity in human breast and bladder cancers.
Jones RJ; Boyce T; Fennell M; Jacobs V; Pinto F; Duffield E; Clack G; Green T; Kelly J; Robertson J
Cancer Chemother Pharmacol; 2008 Jan; 61(1):23-32. PubMed ID: 17909809
[TBL] [Abstract][Full Text] [Related]
20. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
